Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Nicotinic receptor selective cell penetrating peptide for brain cargo delivery

Award Number: R03MH135358
ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 11/10/2023
PERIOD OF PERFORMANCE END DATE: 10/31/2026

Group Awards By:

View Award Description

Nicotinic receptor selective cell penetrating peptide for brain cargo delivery - ABSTRACT. In the U.S., major depressive disorder (MDD) is the most common mental disorder, with depression prevalence approaching 20% among adolescents and young adults. Current pharmacological treatments are unsatisfactory in that 33-55% of people suffering from MDD are non-responsive. MDD is associated with alterations in neurotransmitter systems including hypercholinergic tone modulated by nicotinic acetylcholine receptors (nAChRs) and decreased brain-derived neurotrophic factor (BDNF) expression. nAChRs are abundant in the central nervous system, and hypercholinergic tone, in part caused by α7-nAChR activation, is associated with depression. Pharmacologically desensitizing α7-nAChRs improves depressive symptoms in mice. Common serotonin and norepinephrine reuptake inhibitor therapies antagonize nAChRs non-selectivity (off target effect) and enhance BDNF levels at clinically effective doses. Excitingly, reducing expression of programmed cell death 4 (Pdcd4) protein, a translation inhibitor, by small interfering RNA (siRNA) delivered by a cell penetrating peptide (CPP), enhances BDNF expression to reverse depressive-like behaviors in mice. However, caution must be taken as CPPs interact broadly with cellular macromolecules and lipid bilayers resulting in uncontrolled cargo delivery. To begin to combat this issue, we developed an α7-nAChR selective CPP. Our preliminary data show that the lead CPP is not cytotoxic and can transport a fluorophore into neuronal-like cells by an α7-nAChR dependent mechanism. These underlying findings led us to our hypothesis that the novel lead CPP, a selective α7-nAChR antagonist, coupled with Pdcd4 siRNA may be able to achieve our important goal to help those suffering from MDD. Defining if the lead CPP can move siRNA cargo into cells and mammalian brain will remove critical barriers that stymie scientific and clinical MDD work, in addition to other conditions affected by α7-nAChR dysregulation. We will pursue the aims of this proposal by comparing cell culture and in vivo application of the lead CPP complexed with fluorophore-tagged siRNA to determine if the siRNA can be delivered to cause a cellular effect. We will combine live-cell confocal microscopy, brain imaging, western blot, and ELISA assays. Anticipated outcomes may also reveal potential utility of the lead CPP as a research tool. Application funding will provide foundational support for PI Weltzin’s progress towards becoming an independent researcher by demonstrating project feasibility, assay advancement, preliminary data generation, and a senior-author publication.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $65,875 )
2025	2025	UNIVERSITY OF ALASKA FAIRBANKS	2145 N TANANA LOOP	FAIRBANKS	AK	99775	FAIRBANKS NORTH STAR	USA	Mental Health Research Grants	001	2	9/8/2025	NON-COMPETING CONTINUATION	$0
2025	2025	UNIVERSITY OF ALASKA FAIRBANKS	2145 N TANANA LOOP	FAIRBANKS	AK	99775	FAIRBANKS NORTH STAR	USA	Mental Health Research Grants	000	2	11/20/2024	NON-COMPETING CONTINUATION	$65,875
														Subtotal = $65,875

Issue Date FY: 2024 ( Subtotal = $77,500 )
2024	2024	UNIVERSITY OF ALASKA FAIRBANKS	2145 N. TANANA LOOP	FAIRBANKS	AK	99775	FAIRBANKS NORTH STAR	USA	Mental Health Research Grants	000	1	11/10/2023	NEW	$77,500
														Subtotal = $77,500

Grand Total All Awards = $143,375

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Nicotinic receptor selective cell penetrating peptide for brain cargo delivery

Award Number: R03MH135358

ORGANIZATION: NATIONAL INSTITUTE OF MENTAL HEALTH

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 11/10/2023

PERIOD OF PERFORMANCE END DATE: 10/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer